AMM
Thank you to everyone who joined us virtually and in person at New England Biolabs HQ in Ipswich, MA, for the 2025 AMM Innovation Forum.
Together, we gathered leading minds in mRNA innovation to explore breakthroughs, share insights, and accelerate progress. Watch the highlights in our event recap video.
Nobel Prize in Physiology & Medicine (1993), Chief Scientific Officer, New England Biolabs
Entrepreneur and Former Chief Scientific Officer, Moderna
AMM Board Chair, Chief Development Officer and Co-Founder, Replicate Bioscience
Director, Process Development, Curia
Associate Director RNA Division, New England Biolabs
Chief Scientific Officer, ReciBioPharm
Chief Scientific Officer, Nature’s Toolbox
Chief Scientific Officer, Terrain Bio
SVP, Discovery and Translational Development, Strand Therapeutics
Executive Director, Global Scientific Portfolio Management, Charles River
Dir. of Tech & Translation, Innovative Genomics Institute; Prof. of Molecular & Cellular Biology, UC Berkeley
Prof. Dana Farber Cancer Institute & Harvard Medical School; Chief, Div. of Stem Cell Transplantation & Cellular Therapies
Scientific Advisor to Hongene
Sir Richard Roberts, Nobel Prize in Physiology & Medicine (1993), Chief Scientific Officer, New England Biolabs
Andy Geall, AMM Board Chair
Melissa Moore
Entrepreneur and Former Chief Scientific Officer, Moderna
Tours Available
Breton Hornblower, NEB
The Alliance for mRNA Medicines (AMM) is the leading global organization dedicated to advancing and advocating for mRNA and next-generation encoding RNA therapeutics and vaccines for the benefit of patients, public health, and society. Our mission is to propel the future of mRNA medicine, improve patients’ lives, and advance scientific knowledge by convening and empowering mRNA industry leaders, innovators, scientists, and other key stakeholders.